{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T02:54:26Z","timestamp":1761706466766,"version":"3.41.2"},"reference-count":35,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["R01AI138970"],"award-info":[{"award-number":["R01AI138970"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2023,12,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Shigellosis (bacillary dysentery) is a severe diarrheal disease caused by members of the genus\n            <jats:italic>Shigella<\/jats:italic>\n            , which results in 90 million cases annually around the world. The\n            <jats:italic>Shigella<\/jats:italic>\n            type III secretion system (T3SS) is a specialized secretion system that is the primary virulence factor it uses to infect the colonic mucosa. The type III secretion apparatus (T3SA) proteins IpaB and IpaD, as well as the genetic fusion, DBF, have been demonstrated to protect mice from\n            <jats:italic>Shigella<\/jats:italic>\n            spp. infection in a lethal pulmonary model. In a previous study, we fused LTA1, the active moiety of lethal toxin from enterotoxigenic\n            <jats:italic>Escherichia coli<\/jats:italic>\n            to DBF to produce a self-adjuvanting vaccine candidate L-DBF, which cross-protected mice against four serotypes of\n            <jats:italic>Shigella flexneri<\/jats:italic>\n            and\n            <jats:italic>Shigella sonnei<\/jats:italic>\n            . Here, we exposed mice with one or two sublethal doses of\n            <jats:italic>S. flexneri<\/jats:italic>\n            2a to identify whether the immune response induced by L-DBF in the host would be affected by prior infection by homologous or heterologous\n            <jats:italic>Shigella<\/jats:italic>\n            serotypes. We demonstrate that pre-infection with two sublethal doses of\n            <jats:italic>S. flexneri<\/jats:italic>\n            2a did not elicit cross-protection against\n            <jats:italic>S. sonnei<\/jats:italic>\n            , while vaccination with L-DBF did. Our results indicate that L-DBF is a feasible vaccine candidate that offers cross-protection against\n            <jats:italic>Shigella<\/jats:italic>\n            \u2019s different serotypes even after prior exposure to the pathogen. This work provides a proof of concept that a novel subunit vaccine can not only protect a na\u00efve host from\n            <jats:italic>Shigella<\/jats:italic>\n            challenge, but also can protect against challenge after prior infection by the same or different\n            <jats:italic>Shigella<\/jats:italic>\n            serotypes.\n          <\/jats:p>\n          <jats:sec>\n            <jats:title>IMPORTANCE<\/jats:title>\n            <jats:p>\n              Shigellosis is endemic to low- and middle-income regions of the world where children are especially vulnerable. In many cases, there are pre-existing antibodies in the local population and the effect of prior exposure should be considered in the development and testing of vaccines against\n              <jats:italic>Shigella<\/jats:italic>\n              infection. Our study shows that L-DBF-induced immune responses are not adversely affected by prior exposure to this pathogen. Moreover, somewhat different cytokine profiles were observed in the lungs of vaccinated mice not having been exposed to\n              <jats:italic>Shigella<\/jats:italic>\n              , suggesting that the immune responses elicited by\n              <jats:italic>Shigella<\/jats:italic>\n              infection and L-DBF vaccination follow different pathways.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1128\/spectrum.00062-23","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T13:10:27Z","timestamp":1696338627000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["The L-DBF vaccine cross protects mice against different\n            <i>Shigella<\/i>\n            serotypes after prior exposure to the pathogen"],"prefix":"10.1128","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2706-3223","authenticated-orcid":false,"given":"Ti","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, University of Kansas , Lawrence, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debaki R.","family":"Howlader","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, University of Kansas , Lawrence, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayan","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, University of Kansas , Lawrence, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zackary K.","family":"Dietz","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, University of Kansas , Lawrence, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron C.","family":"Nagel","sequence":"additional","affiliation":[{"name":"Hafion, Inc , Lawrence, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean K.","family":"Whittier","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, University of Kansas , Lawrence, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Picking","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, University of Kansas , Lawrence, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7998-0643","authenticated-orcid":false,"given":"Wendy L.","family":"Picking","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, University of Kansas , Lawrence, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33296-8"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2012.00114"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.07.070"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-021-01054-z"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30475-4"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.03.036"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000170"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25764-3"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03949-8"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22700-4"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.07335"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.12"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9020451"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00440-06"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01599-06"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.06174-11"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00859-13"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00181-12"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.3389\/fitd.2021.729731"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900978"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu468"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.5.1947-1954.1995"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.09.083"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2020.02.006"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1640427"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2014.02.002"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200839148"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03647-4"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2007.07.010"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.13166"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1300981110"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00939-10"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.05.100"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.14202\/vetworld.2022.281-287"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2004.06.021"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00062-23","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00062-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T13:58:32Z","timestamp":1702389512000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.00062-23"}},"subtitle":[],"editor":[{"given":"Neelam","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12,12]]}},"alternative-id":["10.1128\/spectrum.00062-23"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.00062-23","relation":{},"ISSN":["2165-0497"],"issn-type":[{"type":"electronic","value":"2165-0497"}],"subject":[],"published":{"date-parts":[[2023,12,12]]},"assertion":[{"value":"2023-01-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00062-23"}}